leucine has been researched along with Muscular Atrophy, Spinal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, XJ; Ma, L; Mou, Y; Tian, Y; Trinh, J; Wang, Y; Xu, C; Zhang, B; Zhang, X; Zhou, S | 1 |
Bird, LE; Cader, MZ; James, PA; Ren, J; Stammers, DK; Talbot, K | 1 |
2 other study(ies) available for leucine and Muscular Atrophy, Spinal
Article | Year |
---|---|
Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology.
Topics: Animals; Blood-Brain Barrier; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Drug Evaluation, Preclinical; Genes, Reporter; HEK293 Cells; Humans; Ketones; Leucine; Mice; Mitochondria; Motor Neurons; Muscular Atrophy, Spinal; Protective Agents; Protein Stability; Proteolysis; Signal Transduction; Survival of Motor Neuron 2 Protein; Transfection; Treatment Outcome | 2019 |
Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy.
Topics: Amino Acid Substitution; Binding Sites; Crystallography, X-Ray; Dimerization; Distal Myopathies; Glycine-tRNA Ligase; Humans; Leucine; Models, Molecular; Muscular Atrophy, Spinal; Mutant Proteins; Mutation, Missense; RNA-Binding Proteins; Serine; Transfer RNA Aminoacylation | 2007 |